Stocktoria
BIOVIE INC. BIVI
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2014-01-14
BIOVIE INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on assets | -154.9% | -81.4% | -127.4% | -143.2% | -129.7% | -2154.1% | -800.3% | — | -111.9% | -56.3% |
| Return on equity | -214.9% | -92.3% | -207.1% | -327.6% | -710.6% | -2579.0% | 77.6% | — | -2189.0% | -115.0% |
| Debt / equity | — | — | — | — | — | — | -0.00× | — | — | — |
| Current ratio | 3.59 | 9.10 | 2.57 | 2.35 | 4.50 | 4.62 | 0.02 | 1.52 | 0.04 | 0.01 |
Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.